Skip to content

JNJ vs LLY: Dividend Comparison

JNJ$278.81
Johnson & Johnson
Health Care
vs
LLY$1,406.28
ELI LILLY & Co
Health Care

Dividend data as of

Johnson & Johnson (JNJ) and ELI LILLY & Co (LLY) are both in the Health Care sector, making them natural rivals for dividend investors. JNJ offers a significantly higher 1.90% yield compared to LLY's 0.48%, a gap of 1.42%. For dividend growth, LLY leads with a 5-year CAGR of 15.3% versus JNJ's 5.0%. LLY holds the edge in dividend safety with a "Safe" rating. JNJ is a Dividend King while LLY is a Dividend Contender.

Verdict

Best for Income
JNJ
Higher yield at 1.90%
Best for Growth
LLY
5yr CAGR of 15.3%
Best for Safety
LLY
Rated "Safe"

Track JNJ and LLY in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan (1 portfolio, 10 holdings).

30-day free brokerage sync trial. No credit card. Then from $9.99/month. Choosing a tracker? See the best dividend trackers compared.

Metric
Price
$278.81
$1,406.28
Dividend Yield
1.90%
0.48%
Annual Dividend
$5.36
$6.92
5yr Div CAGR
5.0%
15.3%
3yr Div CAGR
4.4%
15.3%
Consecutive Years
61
11
Payout Ratio
80.12%
21.71%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$190/yr
$48/yr

Yield Analysis

JNJ
1.90%
LLY
0.48%

JNJ yields 1.42% more than LLY. In dollar terms, JNJ pays $5.36/share vs LLY's $6.92/share annually.

Dividend Growth

JNJ 5yr CAGR
5.0%
decelerating
LLY 5yr CAGR
15.3%
steady

JNJ: Dividend growth is slowing — the 3-year CAGR of 4.4% trails the 5-year rate of 5.0% and the 10-year rate of 5.3%.

LLY: Dividend growth has been steady, with a 3-year CAGR of 15.3% and a 5-year CAGR of 15.3% (10-year: 13.0%).

Dividend Safety

JNJ
At Risk
Payout Ratio80%
LLY
Safe
Payout Ratio22%

JNJ: The payout ratio of 80% is elevated, which may indicate the dividend could be cut if earnings decline. Earnings cover the dividend 1.2x.

LLY: The payout ratio of 22% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 4.5x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
JNJ
LLY
$10,000
$190/yr
$48/yr
$50,000
$949/yr
$241/yr
$100,000
$1,897/yr
$482/yr

What does $10,000 buy in JNJ vs LLY today?

At $278.81 per share, $10,000 buys about 35.9 shares of Johnson & Johnson (JNJ). Each share pays $5.36 per year in dividends, so the position starts out generating roughly $192 per year — about $16 a month.

At $1406.28 per share, $10,000 buys about 7.1 shares of ELI LILLY & Co (LLY). Each share pays $6.92 per year in dividends, so the position starts out generating roughly $49 per year — about $4 a month.

JNJ is the larger income stream from day one: $143 per year more on the same $10,000 invested.

What could $10,000 of JNJ or LLY income look like in 10 years?

Johnson & Johnson (JNJ) has raised its dividend about 5.0% a year over the past five years. If that pace held, the $190 per year that $10,000 generates today at the current 1.90% yield would reach $308 per year by 2036 — a 3.1% yield on the original cost.

ELI LILLY & Co (LLY) has raised its dividend about 15.3% a year over the past five years. If that pace held, the $48 per year that $10,000 generates today at the current 0.48% yield would reach $200 per year by 2036 — a 2.0% yield on the original cost.

On those trailing rates, JNJ pays more in 2036: $308 versus $200 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would LLY's dividend growth overtake JNJ's higher yield?

ELI LILLY & Co (LLY) yields less today (0.48% vs 1.90%) but has grown its dividend faster — 15.3% vs 5.0% a year over the past five years. If both trends continued, a $10,000 position in LLY would start out-earning the same position in JNJ around 2041 (roughly 15 years from now), paying about $406 per year at the crossover. Before that point, JNJ pays more each year; after it, the gap compounds in LLY's favor.

Can JNJ and LLY afford their dividends?

Johnson & Johnson (JNJ) earns $6.59 per share against $5.36 paid out in dividends — 1.2x coverage (a 80% payout ratio).

ELI LILLY & Co (LLY) earns $30.81 per share against $6.92 paid out in dividends — 4.5x coverage (a 22% payout ratio).

LLY's wider coverage leaves more cushion if earnings dip. As a rule of thumb, coverage below about 1.5x (a payout ratio above ~65%) is where a dividend starts to look stretched — worth watching for JNJ if earnings weaken.

Which fits an early-retirement income portfolio better, JNJ or LLY?

For income you need right now, Johnson & Johnson (JNJ) leads: $100,000 invested today pays about $158 a month at the current 1.90% yield, versus $40 a month from ELI LILLY & Co (LLY) at 0.48%.

With a decade or more before the income is needed, LLY's faster dividend growth (15.3% vs 5.0% a year) matters more than the starting yield — raises compound into the larger paycheck over time.

On consistency: JNJ has raised its dividend 61 consecutive years; LLY has raised its dividend 11 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $372/yr in JNJ vs $209/yr in LLY by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.